Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Qu Biologics Inc.
Please refer to summary above.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female who is at or above the age of consent
Histologically confirmed original diagnosis of lung cancer
Life expectancy greater than 12 months
ECOG performance status 0, 1, or 2 at screening
Female subjects who agree to practice two effective methods of contraception from the time of signing the informed consent form through one month after the last dose of study drug
Male subjects who agree to practice effective barrier contraception during the entire study drug period and through one month after the last dose of study drug
You may not be if
Extra-thoracic lung cancer progression
Any active malignancies
Any uncontrolled or major organ dysfunction
Any past or current radiation or systemic therapies for the treatment of lung cancer
Known HIV infection or other immunosuppressive disorder
Concurrently participating in another study with an investigational immunotherapy or have received investigational immunotherapy within 3 months prior to screening
Clareo Health | Exploratory Study of QBKPN SSI in Non-Small Cell Lung Cancer
